Retatrutide

Retatrutide

What is Retatrutide?
Retatrutide is a new medication to treat obesity, diabetes, and fatty liver disease. Created by the pharmaceutical company Lilly, retatrutide is an experimental drug heading toward phase 3 of clinical trials.


Lilly recently announced remarkable results from phase 2 of the trial, revealing better success than similar drugs.


During the trial phase, people with obesity who took the highest dose in the study lost an average of 17.5% of their starting weight after nearly six months — halfway through. By week 48, subjects lost more than 24% — an average of 58 lbs. Lilly also announced improvements in blood pressure and blood glucose, cholesterol, and insulin levels at weeks 24 and 48 of the trial.


Retatrutide works in three ways
Retatrutide helps people lose weight and lower their blood sugar levels. However, Lilly’s clinical trials also demonstrated a powerful third outcome with retatrutide. Results showed significant improvement in non-alcoholic fatty liver disease(NAFLD), a common and dangerous problem for people with obesity and metabolic syndrome.

Key Benefits

Because retatrutide works in three ways, it is considered a “tri-agonist.”
1. Helps lower blood sugar
2. Promotes weight loss
3. Improves fatty liver disease

Hygiene, Experts, Machinery, Quality, Results, Technology Advancement, Innovation, Post Therapy Support

RE –

ENGINEER

YOUR

INNER

STRENGTH

Contact us

    Review Mirror